Citation Impact

Citing Papers

Rodent-borne diseases and their risks for public health
2009 Standout
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies
2013
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Targeting cancer stem cell pathways for cancer therapy
2020
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
2017 Standout
Medulloblastomics: the end of the beginning
2012
Molecular subgroups of medulloblastoma
2012
New opportunities for field research on the pathogenesis and treatment of Lassa fever
2007
The Molecular Signatures Database Hallmark Gene Set Collection
2015 Standout
New approaches for treatment in diabetes: Aldose reductase inhibitors
1995
TH1 predominance is associated with improved survival in pediatric medulloblastoma patients
2011
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2016 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Identifying brain tumours in children and young adults
2013
Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections
2014
Histological variants of medulloblastoma are the most powerful clinical prognostic indicators
2012
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
MGMT promoter hypermethylation and its associations with genetic alterations in a series of 350 brain tumors
2012
Revolutionizing healthcare: the role of artificial intelligence in clinical practice
2023 Standout
Pharmacokinetics of Oxicam Nonsteroidal Anti-Inflammatory Agents
1994
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
2011
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
2018 Standout
Aldose reductase inhibitors zopolrestat and ferulic acid alleviate hypertension associated with diabetes: effect on vascular reactivity
2012
Lessons Learned from Marketed and Investigational Prodrugs
2004
Childhood and adolescent cancer statistics, 2014
2014 Standout
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
2021 Standout
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates
2011 Standout
Medulloblastoma genomics in the modern molecular era
2019
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018
2021 Standout
Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches
2023
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2019 Standout
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
1999 Standout
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
The contribution of wheat to human diet and health
2015 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout

Works of Nicolas U. Gerber being referenced

Outcome Prediction in Pediatric Medulloblastoma Based on DNA Copy-Number Aberrations of Chromosomes 6q and 17q and the MYC and MYCN Loci
2009
Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy
2009
Safety, Tolerance and Pharmacokinetics of Intravenous Doses of the Phosphate Ester of 3‐Hydroxymethyl‐5,5‐Diphenylhydantoin: A New Prodrug of Phenytoin
1988
Pharmacokinetics of the Aldose Reductase Inhibitor, Zopolrestat, in Humans
1994
Envelope Exchange for the Generation of Live-Attenuated Arenavirus Vaccines
2006
Large cell/anaplastic medulloblastoma: Outcome according to myc status, histopathological, and clinical risk factors
2009
Treatment of young children with localized medulloblastoma by chemotherapy alone: Results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology
2011
Disposition of ampiroxicam, a prodrug of piroxicam, in man
1990
Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trial
2022
Expression of O6-methylguanine-DNA methyltransferase in childhood medulloblastoma
2010
Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT‘91
2009
Rankless by CCL
2026